Ovid Therapeutics Inc. (OVID) financial statements (2022 and earlier)

Company profile

Business Address 1460 BROADWAY
NEW YORK, NY 10036
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:187,79872,03476,70041,50087,126
Cash and cash equivalents187,79872,03441,89736,49087,126
Short-term investments  34,8425,011 
Other undisclosed cash, cash equivalents, and short-term investments  (39)(1) 
Other undisclosed current assets2,6822,8093,1132,7681,462
Total current assets:190,47974,84379,81344,26888,588
Noncurrent Assets
Property, plant and equipment243136687052
Long-term investments and receivables1,632    
Long-term investments1,632    
Intangible assets, net (including goodwill)164    
Intangible assets, net (excluding goodwill)164    
Prepaid expense 4773602,798 
Other noncurrent assets164319467392729
Other undisclosed noncurrent assets1,86315113512289
Total noncurrent assets:4,0661,0821,0313,381870
TOTAL ASSETS:194,54575,92680,84447,65089,458
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities14,79817,47910,5238,8446,021
Accounts payable7,1275,4463,2563,7562,026
Accrued liabilities7,67112,0337,2675,0893,995
Deferred revenue 2,213 
Due to related parties 2,37111  
Total current liabilities:14,79822,06310,5348,8446,021
Noncurrent Liabilities
Liabilities, other than long-term debt 10,231287  
Deferred revenue 10,170 
Due to related parties 61287  
Total noncurrent liabilities: 10,231287  
Total liabilities:14,79832,29410,8208,8446,021
Stockholders' equity
Stockholders' equity attributable to parent179,74643,63270,02438,80583,437
Preferred stock000  
Common stock7066552525
Additional paid in capital351,034337,758283,123191,478184,128
Accumulated other comprehensive income (loss)  2(2) 
Accumulated deficit(171,358)(294,192)(213,157)(152,695)(100,716)
Total stockholders' equity:179,74643,63270,02438,80583,437
TOTAL LIABILITIES AND EQUITY:194,54575,92680,84447,65089,458

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues208,38312,617   
Gross profit:208,38312,617   
Operating expenses(84,174)(94,048)(61,409)(52,932)(65,008)
Operating income (loss):124,209(81,431)(61,409)(52,932)(65,008)
Nonoperating income  948952202
Income (loss) from continuing operations before equity method investments, income taxes:124,209(81,431)(60,461)(51,980)(64,806)
Other undisclosed loss from continuing operations before income taxes(46)    
Income (loss) from continuing operations before income taxes:124,163(81,431)(60,461)(51,980)(64,806)
Income tax expense(1,329)    
Net income (loss):122,835(81,431)(60,461)(51,980)(64,806)
Other undisclosed net income attributable to parent 395   
Net income (loss) attributable to parent:122,835(81,036)(60,461)(51,980)(64,806)
Undistributed earnings (loss) allocated to participating securities, basic(2,997)    
Other undisclosed net income available to common stockholders, basic2    
Net income (loss) available to common stockholders, diluted:119,839(81,036)(60,461)(51,980)(64,806)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income (loss):122,835(81,431)(60,461)(51,980)(64,806)
Other comprehensive income (loss) (2)4(2) 
Comprehensive income (loss):122,835(81,433)(60,457)(51,981)(64,806)
Other undisclosed comprehensive income, net of tax, attributable to parent 395   
Comprehensive income (loss), net of tax, attributable to parent:122,835(81,038)(60,457)(51,981)(64,806)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: